MDMA psychotherapy for PTSD was approved in Australia back in July 2023.
Near to three years on, what do we know about how it’s being used, whether people are finding it effective and how well we’re tracking the possible side effects of these treatments?
Guest/s
- Associate Professor Gill Bedi, Head of Substance Use Research, Orygen
References
